Pretargeted Radioimmunotherapy with the Novel Anti-oxMIF/HSG Bispecific Antibody ON105 Results in Significant Tumor Regression in Murine Models of Cancer
Article in Molecular Cancer Therapeutics (July 2024)
The most recent citing publications are shown below. View all 33 publications that cite this research output on Dimensions.
Article in Molecular Cancer Therapeutics (July 2024)
Book chapter (November 2023)
Article in Pharmaceutics (April 2023)